CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation
Authors:
Open Access
- 27 April 2023
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 91, 104589
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (APP1193648)
- National Health and Medical Research Council (APP 1176660)
- University of Sydney
- Petre Foundation
- Cerebral Palsy Alliance
This publication has 74 references indexed in Scilit:
- International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitionsMultiple Sclerosis Journal, 2013
- Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic PainMediators of Inflammation, 2013
- Quinolinic Acid: An Endogenous Neurotoxin with Multiple TargetsOxidative Medicine and Cellular Longevity, 2013
- Viral disruption of the blood–brain barrierTrends in Microbiology, 2012
- Central nervous system inflammation in disease related conditions: Mechanistic prospectsBrain Research, 2012
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- The role of inflammation in epilepsyNature Reviews Neurology, 2010
- The role of inflammation in CNS injury and diseaseBritish Journal of Pharmacology, 2006
- Quinolinic Acid is Increased in CSF and Associated with Mortality after Traumatic Brain Injury in HumansJournal of Cerebral Blood Flow & Metabolism, 1998
- Acute behaviour disturbances.Journal of Neurology, Neurosurgery & Psychiatry, 1993